Navigation Links
Queensland technology licensed by billion-dollar US company
Date:2/15/2008

University of Queensland scientists have developed a proprietary technology that will help other researchers in understanding fundamental aspects of growth, development, and disease, which has been licensed to one of the world's largest life science technology companies.

Dr Marcel Dinger and Professor John Mattick, from UQ's Institute for Molecular Bioscience, have designed a new type of microarray RNA chip, used by researchers to analyse which genes are being expressed at any one time in a particular cell.

The technology has been licensed through IMBcom, UQ's company for the commercialisation of intellectual property arising from research conducted at the IMB. It was licensed to Invitrogen, a provider of essential life science technologies for research, production and diagnostics with a 2006 revenue of US$1.15 billion.

Every cell in the body contains a full set of genes, but different cells express different subsets, Professor Mattick said. In the past these genes were thought only to code mainly for proteins, via the production of "messenger RNAs", but it is now evident that many other genes produce non-coding RNAs whose functions have yet to be determined.

It appears that we have misunderstood the nature of genetic programming in humans and other complex organisms, Professor Mattick said. Most of the genome is transcribed, mainly into non-coding RNAs, which appear to comprise a hidden layer of gene regulation whose full dimensions are just beginning to be explored.

There is increasing recognition that these non-coding RNAs control various levels of gene expression in physiology and development, as well as in the brain.

Products commercialized by Invitrogen will be based on a novel set of RNA probes that Dr Dinger and Professor Mattick have designed, which can uniquely identify tens of thousands of coding and non-coding RNA sequences. This is the first time that one product has been able to identify both large numbers of protein-coding and non-coding RNAs.

This technology will allow researchers to obtain more accurate information about the relationship between messenger and non-coding RNA expression, Dr Peter Isdale, CEO of IMBcom, said. It has the potential to make a real impact in cancer and stem cell research, as these RNAs are implicated in both of these areas.


'/>"/>

Contact: Bronwyn Adams
communications@uq.edu.au
61-733-462-134
Research Australia
Source:Eurekalert

Related medicine news :

1. Fluoridated water for Queensland ... at last
2. Queensland businessman is one in a million
3. QueensLander Tours Presents an Adventure Boot Camp Cruise with John Spencer Ellis from Bravos The Real Housewives of Orange County
4. Quantum light beams good for fast technology
5. New Smart Technology Makes Patient Data Collection Easier, More Efficient
6. Align Technology Executive to Present at Upcoming Financial Conferences
7. Pioneer Surgical Technology Hires Vice President of New Business Development
8. Purdue researchers develop technology to detect cancer by scanning surface veins
9. Creative Technology Services Enhances its Global Competitiveness with Additional Regulatory Certifications
10. University of Wisconsin Hospitals and Clinics Complete System-Wide Conversion to Masimo SET Pulse Oximetry Technology
11. Patent Reform Legislation Threatens Americas Leadership in Medical Technology Innovation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... ... May 25, 2016 , ... Today Omega Institute, a leading destination ... innovative workshops and training opportunities in the growing field of yoga therapy ... who are dealing with specific health issues—including injuries, illnesses, and temporary or chronic health ...
(Date:5/25/2016)... ... May 25, 2016 , ... The Global Wellness Summit (GWS) today announced that ... offerings of Europe, a continent that pioneered the medical/wellness concept for the world. , ... in medical wellness, including Henri Chenot, Founder of the Chenot Group, which operates wellness ...
(Date:5/25/2016)... Harrisburg, PA (PRWEB) , ... May 25, 2016 ... ... today announced the results of its annual Medical and Prescription Drug survey ... health benefits. , The survey, which was conducted in December 2015, indicates ...
(Date:5/25/2016)... ... May 25, 2016 , ... Laser Skin & ... turn back the hands of time of female aging. The Juliet™ ... Women with symptoms such as leakage, laxity, itchiness and pain have reported real relief ...
(Date:5/25/2016)... ... 25, 2016 , ... Consumer access to organic foods and grower access to ... of whole grain cereals and other plant-based foods, will introduce the first consumer product ... wheat processed by Hesco/Dakota Organic Products. , The transitional designation means the cereal was ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... 24, 2016 The innovator ... , s first dual therapy stent, introduces ... OrbusNeich, a global company specializing in the ... to include products to treat peripheral artery disease. The ... entry devices for lower limb and arteriovenous (AV) fistula ...
(Date:5/24/2016)... , May 24, 2016 Een ... verbindt, zodat zij collectief patiënten kunnen behandelen, hun kennis ... het idee achter de nieuwe en revolutionaire MDLinking App, ... de Nederlandse vaatchirurg dr. Hans Flu en oncologisch chirurg ... die inmiddels beschikbaar is, wordt op dinsdag 24 mei ...
(Date:5/23/2016)... , May 23, 2016 ... Market Size, Share, Development, Growth and Demand Forecast ... Single and Other), by Application (Drug Discovery and ... End Users (Pharmaceuticals, Life Science and Biotechnology, Academic ... P&S Market Research, the global mass spectrometry ...
Breaking Medicine Technology: